Showing results (241-250 of 266) with videos related to
Sort By:
Pageof 27
EJNMMI Radiopharmacy and Chemistry|July 31, 2020
Automated [18F]PSMA-1007 production by a single use cassette-type synthesizer for clinical examinationSadahiro Naka, Tadashi Watabe, Kenta Kurimoto, et al.Cancers|August 27, 2021
Magnetic Resonance Relaxometry for Tumor Cell Density Imaging for Glioma: An Exploratory Study via 11C-Methionine PET and Its Validation via Stereotactic Tissue SamplingManabu Kinoshita, Masato Uchikoshi, Souichiro Tateishi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2011
Early [18F]fluorodeoxyglucose positron emission tomography at two days of gefitinib treatment predicts clinical outcome in patients with adenocarcinoma of the lungRyo Takahashi, Haruhiko Hirata, Isao Tachibana, et al.Oncology Letters|February 12, 2021
In vivo evaluation of percutaneous carbon dioxide treatment for improving intratumoral hypoxia using 18F-fluoromisonidazole PET-CTKoji Maruyama, Takuya Okada, Takeshi Ueha, et al.Cancer Science|August 9, 2017
Metabolic tumor volume of primary tumor predicts survival better than T classification in the larynx preservation approachJunji Miyabe, Atsushi Hanamoto, Mitsuaki Tatsumi, et al.Journal of Medicinal Chemistry|October 28, 2021
Neopentyl Glycol as a Scaffold to Provide Radiohalogenated Theranostic Pairs of High In Vivo StabilityHiroyuki Suzuki, Yuta Kaizuka, Maho Tatsuta, et al.Cancer Science|December 5, 2020
α-Emitting cancer therapy using 211 At-AAMT targeting LAT1Kazuko Kaneda-Nakashima, ZiJian Zhang, Yoshiyuki Manabe, et al.Journal of Neurosurgery|September 22, 2018
11C-methionine-18F-FDG dual-PET-tracer-based target delineation of malignant glioma: evaluation of its geometrical and clinical features for planning radiation therapyTakero Hirata, Manabu Kinoshita, Keisuke Tamari, et al.Cureus|July 5, 2024
An Overview of Appropriate Medical Practice and Preparedness in Radiation Emergency ResponseAkram Al-Ibraheem, Serin Moghrabi, Ahmed Abdlkadir, et al.Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Evaluation of 64Cu-Labeled New Anti-EGFR Antibody NCAB001 with Intraperitoneal Injection for Early PET Diagnosis of Pancreatic Cancer in Orthotopic Tumor-Xenografted Mice and Nonhuman PrimatesHiroki Matsumoto, Tadashi Watabe, Chika Igarashi, et al.Pageof 27